Abbott Molecular, a genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases. The Company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies.
Type
Public
HQ
Illinois City, US
Founded
1991
Size (employees)
99,000 (est)+32%
Website
abbott.com
Abbott was founded in 1991 and is headquartered in Illinois City, US
Report incorrect company information

Key People/Management at Abbott

Miles White

Miles White

CEO
Stephen Fussell

Stephen Fussell

Executive Vice President, Human Resources
Corlis Murray

Corlis Murray

Senior Vice President, Quality Assurance, Regulatory and Engineering Services
Show more

Abbott Office Locations

Abbott has offices in Illinois City, Sao Paulo, Shanghai, Beijing and in 5 other locations
Illinois City, US (HQ)
Abbott Park
Sao Paulo, BR
Rua Michigan, 735 – Brooklin
Québec, CA
8401 Trans-Canada Highway, Saint-Laurent
Beijing, CN
17F, Canway Builing, No. 66 Nanlishi Road
Shanghai, CN
23F/26F/27F/28F/32F/33F/36F/37F/39F, Ciro’s Plaza, No. 388 West Nanjing Road
Wiesbaden, DE
Abbott GmbH & Co. KG, Max-Planck-Ring 2
Show all (9)
Report incorrect company information

Abbott Financials and Metrics

Abbott Revenue

Abbott's revenue was reported to be $27.39 b in FY, 2017 which is a 31.3% increase from the previous period.
USD

Revenue (Q2, 2018)

15.2 b

Gross profit (Q2, 2018)

8.8 b

Gross profit margin (Q2, 2018), %

58.1%

Net income (Q2, 2018)

1.2 b

EBIT (Q2, 2018)

1.5 b

Market capitalization (16-Aug-2018)

112.6 b

Closing stock price (16-Aug-2018)

64.2

Cash (30-Jun-2018)

3.1 b

EV

130.2 b
Abbott's current market capitalization is $112.6 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

21.8 b20.2 b20.4 b20.9 b27.4 b

Revenue growth, %

(7%)1%2%31%

Cost of goods sold

10 b9.2 b8.7 b9 b

Gross profit

11.8 b11 b11.7 b11.8 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

5.4 b5.2 b5.6 b5.1 b4.9 b5.2 b5.2 b4.9 b5.3 b5.3 b6.3 b6.6 b7.4 b15.2 b

Cost of goods sold

2.5 b2.5 b2.5 b2.3 b2.1 b2.2 b2.2 b2.1 b2.3 b2.3 b3 b3.2 b3.1 b6.3 b

Gross profit

2.9 b2.8 b3 b2.8 b2.8 b3 b2.9 b2.7 b3 b3 b3.3 b3.5 b4.3 b8.8 b

Gross profit Margin, %

54%53%55%54%58%57%56%56%57%57%52%52%58%58%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.5 b4.1 b5 b18.6 b

Accounts Receivable

4 b3.6 b3.4 b3.2 b

Inventories

2.7 b2.6 b2.6 b2.4 b

Current Assets

19.2 b15.3 b14.2 b26.8 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

2.9 b2.1 b3.6 b3.6 b3.2 b4 b3.1 b3.3 b2.6 b2.5 b8.7 b9.7 b3.9 b3.1 b

Inventories

2.8 b2.8 b2.8 b2.7 b2.6 b2.7 b2.6 b2.8 b2.8 b2.6 b4 b3.6 b3.8 b3.7 b

Current Assets

19.7 b17.9 b18.3 b16.5 b20 b21.1 b15.9 b12.4 b13 b13 b19.3 b20 b15 b14.1 b

Goodwill

9.7 b9.8 b9.8 b10 b9.9 b9.9 b9.8 b9.8 b9.8 b7.8 b21.4 b22.1 b24.2 b23.8 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.6 b2.3 b4.4 b1.4 b

Inventories

(154 m)(297 m)(257 m)(98 m)

Accounts Payable

256 m225 m742 m652 m

Cash From Operating Activities

3.3 b3.7 b3 b3.2 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Net Income

965.7 m375 m466 m538 m2.3 b3.1 b3.7 b316 m931 m602 m419 m702 m418 m1.2 b

Depreciation and Amortization

723 m1.1 b347 m694 m1 b774 m1.4 b852 m1.7 b

Inventories

(210 m)(213 m)(95 m)(149 m)(152 m)(162 m)(127 m)(171 m)(336 m)

Cash From Operating Activities

943 m2.1 b816 m2 b1.9 b1.1 b2.4 b
USDY, 2018

EV/EBIT

87.4 x

EV/CFO

55.3 x
Show all financial metrics

Abbott Operating Metrics

FY, 2014FY, 2015FY, 2016

New Product Launches

38

Products

10 k1.50 k1.50 k
Show all operating metrics

Abbott Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Alere August 14, 2017$5.30 b
St. Jude Medical April 28, 2016$25 b
Kalila Medical April 06, 2016
Report incorrect company information

Abbott Online and Social Media Presence

Embed Graph
Report incorrect company information

Abbott Company Life and Culture

Report incorrect company information